Literature DB >> 19926843

Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study.

Lars Marquardt1, Olivia C Geraghty, Ziyah Mehta, Peter M Rothwell.   

Abstract

BACKGROUND AND
PURPOSE: The annual risk of ischemic stroke distal to > or =50% asymptomatic carotid stenoses was approximately 2% to 3% in early cohort studies and subsequent randomized trials of endarterectomy. This risk might have fallen in recent years owing to improvements in medical treatment, but there are no published prognostic data from studies initiated within the last 10 years.
METHODS: In a population-based study of all patients with transient ischemic attack (TIA) or stroke in the Oxford Vascular Study, we studied the risk of TIA and stroke in patients with > or =50% contralateral asymptomatic carotid stenoses recruited consecutively from 2002 to 2009 and given intensive contemporary medical treatment.
RESULTS: Of 1153 consecutively imaged patients presenting with stroke or TIA, 101 (8.8%) had > or =50% asymptomatic carotid stenoses (mean age, 75 years; 39% women; 40% age > or =80 years). During 301 patient-years of follow-up (mean, 3 years), there were 6 ischemic events in the territory of an asymptomatic stenosis, 1 minor stroke (initially 50% to 69% stenosis), and 5 TIAs (2 initially 50% to 69% stenosis; 3 to 70% to 99% stenosis), 3 of which led to subsequent endarterectomy. The average annual event rates on medical treatment were 0.34% (95% CI, 0.01 to 1.87) for any ipsilateral ischemic stroke, 0% (95% CI, 0.00 to 0.99) for disabling ipsilateral stroke, and 1.78% (95% CI, 0.58 to 4.16) for ipsilateral TIA.
CONCLUSIONS: In the first study of the prognosis of > or =50% asymptomatic carotid stenosis to be initiated in the last 10 years, the risk of stroke on intensive contemporary medical treatment was low. Larger studies are required to determine whether this apparent improvement in prognosis is generalizable.

Entities:  

Mesh:

Year:  2009        PMID: 19926843     DOI: 10.1161/STROKEAHA.109.561837

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  82 in total

1.  Cerebrovascular disease: Identifying high-risk patients from carotid plaque composition.

Authors:  J David Spence
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

2.  Does current practice in the United States of carotid artery stent placement benefit asymptomatic octogenarians?

Authors:  K C Young; B S Jahromi
Journal:  AJNR Am J Neuroradiol       Date:  2010-09-23       Impact factor: 3.825

Review 3.  Update on surgical management for asymptomatic carotid stenosis.

Authors:  Margaret H Walkup; Peter L Faries
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

4.  Intensive medical therapy for asymptomatic carotid artery stenosis.

Authors:  Pratik Bhattacharya; Seemant Chaturvedi
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

Review 5.  Carotid Disease Management: Surgery, Stenting, or Medication.

Authors:  Priyank Khandelwal; Seemant Chaturvedi
Journal:  Curr Cardiol Rep       Date:  2015-09       Impact factor: 2.931

Review 6.  Stroke: advances in medical therapy and acute stroke intervention.

Authors:  Kevin M Barrett; Brajesh K Lal; James F Meschia
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

7.  Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial.

Authors:  William J Powers; William R Clarke; Robert L Grubb; Tom O Videen; Harold P Adams; Colin P Derdeyn
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

8.  [Treatment of asymptomatic carotid artery stenosis: improvement of evidence with new SPACE-2 design necessary].

Authors:  T Reiff; H Amiri; P A Ringleb; O Jansen; W Hacke; H H Eckstein; G Fraedrich; H Mudra; U Mansmann
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

9.  Secular Trends in Procedural Stroke or Death Risks of Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis.

Authors:  Mandy D Müller; Stefanie von Felten; Ale Algra; Jean-Pierre Becquemin; Richard Bulbulia; David Calvet; Hans-Henning Eckstein; Gustav Fraedrich; Alison Halliday; Jeroen Hendrikse; George Howard; John Gregson; Olav Jansen; Martin M Brown; Jean-Louis Mas; Thomas G Brott; Peter A Ringleb; Leo H Bonati
Journal:  Circ Cardiovasc Interv       Date:  2019-08-05       Impact factor: 6.546

10.  Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.

Authors:  Tanya N Turan; Jenifer H Voeks; Marc I Chimowitz; Ana Roldan; Todd LeMatty; William Haley; Maria Lopes-Virella; Seemant Chaturvedi; Michael Jones; Donald Heck; George Howard; Brajesh K Lal; James F Meschia; Thomas G Brott
Journal:  Stroke       Date:  2020-09-21       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.